VICR director sells 15,242 shares after option exercises
Vicor Corporation (VICR) director Andrew D'Amico reported exercising options and selling the resulting shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Vicor Corporation (VICR) director Andrew D'Amico reported exercising options and selling the resulting shares. Across 10/22/2025–10/23/2025, he exercised and sold a total of 15,242 shares, with exercises at strike prices ranging from $25.30 to $75.43 and sales at prices from $80 to $90. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2024.
The derivative table lists multiple non‑qualified stock option exercises tied to underlying common shares, with footnoted terms stating options expire 2 years from each vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non Qualified Stock Option | 565 | $0.00 | $0.00 |
| Exercise | Common Stock | 565 | $75.43 | $43K |
| Sale | Common Stock | 565 | $90.00 | $51K |
| Exercise | Non Qualified Stock Option | 4,500 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 3,100 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 565 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 1,600 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 995 | $0.00 | $0.00 |
| Exercise | Non Qualified Stock Option | 3,917 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,500 | $25.30 | $89K |
| Sale | Common Stock | 3,500 | $80.00 | $280K |
| Exercise | Common Stock | 1,000 | $25.30 | $25K |
| Sale | Common Stock | 1,000 | $82.00 | $82K |
| Exercise | Common Stock | 1,000 | $36.60 | $37K |
| Sale | Common Stock | 1,000 | $84.00 | $84K |
| Exercise | Common Stock | 1,000 | $36.60 | $37K |
| Sale | Common Stock | 1,000 | $86.00 | $86K |
| Exercise | Common Stock | 1,100 | $36.60 | $40K |
| Sale | Common Stock | 1,100 | $88.00 | $97K |
| Exercise | Common Stock | 565 | $75.43 | $43K |
| Sale | Common Stock | 565 | $85.00 | $48K |
| Exercise | Common Stock | 1,600 | $60.61 | $97K |
| Sale | Common Stock | 1,600 | $80.00 | $128K |
| Exercise | Common Stock | 332 | $60.37 | $20K |
| Sale | Common Stock | 332 | $84.00 | $28K |
| Exercise | Common Stock | 332 | $60.37 | $20K |
| Sale | Common Stock | 332 | $86.00 | $29K |
| Exercise | Common Stock | 331 | $60.37 | $20K |
| Sale | Common Stock | 331 | $88.00 | $29K |
| Exercise | Common Stock | 2,917 | $41.61 | $121K |
| Sale | Common Stock | 2,917 | $80.00 | $233K |
| Exercise | Common Stock | 1,000 | $41.61 | $42K |
| Sale | Common Stock | 1,000 | $87.50 | $88K |
Footnotes (2)
- F1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
- F2. Options expire 2 years from each vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did VICR director Andrew D'Amico report on Form 4?
Were the VICR stock sales under a 10b5-1 plan?
What were the option exercise prices in the VICR Form 4?
What type of derivatives did the insider exercise?
What is the option expiration term noted?
What is Andrew D'Amico’s relationship to VICR?
AI-generated analysis. How Rhea-AI works. Not financial advice.